Oral mucositis (OM) is the inflammation of oral mucosa and is manifested by pain and erythema or ulcerations. This condition is generally seen as a complication due to side effects of chemotherapy and radiotherapy in cancer patients. The systemic effects of cytotoxic chemotherapy agents and radiation effects on oral mucosa led to oral mucositis.

1. Oral Mucositis Therapeutics Market: Global Industry Analysis and Forecast 2015 -
2021
Persistence Market Research
Oral Mucositis Therapeutics Market: Global
Industry Analysis and Forecast 2015 - 2021
Persistence Market Research 1

2. Oral Mucositis Therapeutics Market: Global Industry Analysis and Forecast 2015 -
2021
Persistence Market Research Released New Market Report on “Oral Mucositis Therapeutics
Market: Global Industry Analysis and Forecast 2015 - 2021”.
Oral mucositis (OM) is the inflammation of oral mucosa and is manifested by pain and erythema or
ulcerations. This condition is generally seen as a complication due to side effects of chemotherapy and
radiotherapy in cancer patients. The systemic effects of cytotoxic chemotherapy agents and radiation
effects on oral mucosa led to oral mucositis. The National Institutes of Health estimates that more than
400,000 patients in the U.S. are diagnosed with oral mucositis annually. Since the prevalence of cancer
patients is on rise across the globe, the market for OM therapeutics is also expanding. In addition, the
pain emanated from oral mucositis and the resultant need to cure the condition at the earliest is the
foremost driver for the growth of this market.
Buy Full Report: http://www.persistencemarketresearch.com/market-research/oral-mucositis-
therapeutics-market.asp
The oral mucositis therapeutics market includes several kinds of drug formulations and treatments such
as cryotherapy, growth factors, antioxidants, anti-inflammatory agents, low-level laser therapy (LLLT),
mouthwashes, barriers and coating agents. On the basis of geography, the global oral mucositis
therapeutics market is segmented into four major regions, namely, North America, Europe, Asia-Pacific
and Rest of the World. North America is the largest market for OM therapeutics, closely followed by the
European region.
The currently marketed major preparations for oral mucositis are Gelclair, Caphosol and Kepivance.
Recently, the FDA granted "Fast Track" Designation for SGX942 (Soligenix, Inc.) for the treatment of oral
mucositis in patients with head and neck cancer. This drug along with MuGard (tasteless viscous mouth
rinse) and pipeline candidate drug nepidermin (Daewoong Pharmaceutical Co.) are expected to further
drive the oral mucositis therapeutics market. The major restraint for the development of this market is that
most of the drugs are not to be ingested and therefore restricts their usage for esophageal ulcers.
Some of the key players in the global oral mucositis therapeutics market include Access Pharmaceuticals,
Inc., EKR Therapeutics, Inc., EUSA Pharma Inc., Swedish Orphan Biovitrum Ltd., Soligenix, Inc.,
Daewoong Pharmaceutical Co., Eisai Inc., and BioAlliance Pharma SA.
Request Full TOC: http://www.persistencemarketresearch.com/toc/5585
Persistence Market Research 2

3. Oral Mucositis Therapeutics Market: Global Industry Analysis and Forecast 2015 -
2021
Key points covered in the report:-
1. Report segments the market on the basis of types, application, products, technology, etc
(as applicable)
2. The report covers geographic segmentation
 North America
 Europe
 Asia
 RoW
3. The report provides the market size and forecast for the different segments and
geographies for the period of 2010 to 2020
4. The report provides company profiles of some of the leading companies operating in the
market
5. The report also provides porters five forces analysis of the market.
Browse the full “All Upcoming Persistence Market's ” report at
http://www.persistencemarketresearch.com/forthcoming-reports.asp
About Us:
Persistence Market Research is a global market research firm specializing- syndicated
research, custom research, and consulting services
At Persistence Market Research (PMR), we are in the business of accelerating your business.
As a full-service market research firm, we stand committed to bringing more accuracy and
speed to your business decisions. From ready-to-purchase market research reports to
customized global research solutions, our engagement models are highly flexible without
compromising on our deep-seated research values. Briefly stated, our mission is to give you
access to forecasts and trends analyses that put you on the path to profitability.
PMR’s Services Go Beyond Gleaning Data:
Most enterprises believe that IT and databases are enough to make an accurate decision. While
we do not dispute that, consider this: How long does it take to make an accurate and strategic
million-dollar decision? We strive to deliver both even with demanding deadlines.
Facilitating Rapid and Informed Business Decisions
PMR was founded with one goal in mind: to offer enterprises a tangible business advantage by
carefully balancing traditional and modern-day research methodologies.
Contact Us:
Persistence Market Research 3

4. Oral Mucositis Therapeutics Market: Global Industry Analysis and Forecast 2015 -
2021
Addie Thomes
305 Broadway,
7th Floor,
New York City, NY 10007,
United States.
Phone: +1-646-568-7751
USA/Canada Toll Free Number.
1-800-961-0353
E-mail: Sales@persistencemarketresearch.com
Web : http://www.persistencemarketresearch.com/
Persistence Market Research 4